Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Edrophonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 7/20 | 0.83 |
| ▸ | BLM | P54132 | 1/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.83 |
| ▸ | TSHR | P16473 | 3/20 | 0.80 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.80 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Edrophonium SCHEMBL19148596 | 0.91 | ACHE (1.00) | ACHEBLMSMN1; SMN2TSHROPRM1 | |
| Edrophonium SCHEMBL34789 | 0.91 | ACHE (1.00) | ACHEBLMSMN1; SMN2TSHROPRM1 | |
| Edrophonium SCHEMBL10893551 | 0.90 | ACHE (0.96) | ACHEBLMSMN1; SMN2TSHROPRM1 | |
| Edrophonium SCHEMBL8009388 | 0.89 | ACHE (1.00) | ACHEBLMSMN1; SMN2TSHROPRM1 | |
| Edrophonium SCHEMBL34790 | 0.89 | ACHE (1.00) | ACHEBLMSMN1; SMN2TSHROPRM1 | |
| Edrophonium SCHEMBL29627074 | 0.89 | ACHE (1.00) | ACHEBLMSMN1; SMN2TSHROPRM1 | |
| Edrophonium SCHEMBL2462104 | 0.88 | ACHE (1.00) | ACHEBLMSMN1; SMN2TSHROPRM1 | |
| Edrophonium SCHEMBL10893553 | 0.88 | ACHE (0.96) | ACHEBLMSMN1; SMN2TSHROPRM1 | |
| SCHEMBL4611923 | 0.74 | ACHE (0.71) | ACHEBLMSMN1; SMN2TSHROPRM1 | |
| SCHEMBL4611780 | 0.72 | ACHE (0.68) | ACHEBLMSMN1; SMN2TSHROPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008116165-A9 | METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION | NEXT SAFETY INC (US) | 2009-06-11 | — | — | WO | claimed |
| WO-2008116165-A2 | METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION | NEXT SAFETY, INC. (US) | 2008-09-25 | — | — | WO | claimed |
| US-20080066741-A1 | METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION | HUNTER, CHARLES ERIC | 2008-03-20 | — | — | US | claimed |
| US-20240123168-A1 | PRODUCT DELIVERY DEVICES AND METHODS | MUSTAPHA JIHAD A (US) | 2024-04-18 | — | — | US | disclosed |
| EP-4255541-A1 | PRODUCT DELIVERY DEVICES AND METHODS | Breathe Restore, Inc. (US) | 2023-10-11 | — | — | EP | disclosed |
| US-20230181847-A1 | PRODUCT DELIVERY DEVICES AND METHODS | BREATHE RESTORE INC (US) | 2023-06-15 | — | — | US | disclosed |
| US-11672929-B2 | Product delivery devices and methods | BREATHE RESTORE, INC. (US) | 2023-06-13 | — | — | US | disclosed |
| WO-2022118225-A1 | PRODUCT DELIVERY DEVICES AND METHODS | BREATHE RESTORE, INC. (US) | 2022-06-09 | — | — | WO | disclosed |
| US-20220168516-A1 | PRODUCT DELIVERY DEVICES AND METHODS | BREATHE RESTORE, INC. | 2022-06-02 | — | — | US | disclosed |
| US-9731012-B2 | Laser-actuated therapeutic nanoparticles | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-08-15 | — | — | US | disclosed |
| US-9554989-B2 | Silk reservoirs for drug delivery | TRUSTEES OF TUFTS COLLEGE (US) | 2017-01-31 | — | — | US | disclosed |
| US-20150065685-A1 | LASER-ACTUATED THERAPEUTIC NANOPARTICLES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2015-03-05 | — | — | US | disclosed |
| US-20150045764-A1 | SILK RESERVOIRS FOR DRUG DELIVERY | TRUSTEES OF TUFTS COLLEGE | 2015-02-12 | — | — | US | disclosed |
| EP-2827884-A1 | SILK RESERVOIRS FOR DRUG DELIVERY | Trustees Of Tufts College (US) | 2015-01-28 | — | — | EP | disclosed |
| WO-2013148158-A1 | LASER-ACTUATED THERAPEUTIC NANOPARTICLES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2013-10-03 | — | — | WO | disclosed |
| WO-2013142119-A1 | SILK RESERVOIRS FOR DRUG DELIVERY | TRUSTEES OF TUFTS COLLEGE (US) | 2013-09-26 | — | — | WO | disclosed |
| EP-1911481-A2 | Methods and systems of delivering medication via inhalation | Next Safety, Inc. (US) | 2008-04-16 | — | — | EP | disclosed |